Benzinga | Aug 12, 2021 05:00PM EDT

Atea Pharmaceuticals Q2 EPS $0.02 Up From $(0.99) YoY

Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly earnings of $0.02 per share. This is a 102.02 percent increase over losses of $(0.99) per share from the same period last year.